SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 18.52 |
| Enterprise Value ($M) | -3.02 |
| Book Value ($M) | 7.27 |
| Book Value / Share | 0.36 |
| Price / Book | 2.55 |
| NCAV ($M) | 7.27 |
| NCAV / Share | 0.36 |
| Price / NCAV | 2.55 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.08 |
| Return on Assets (ROA) | -0.03 |
| Return on Equity (ROE) | -0.08 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 9.30 |
| Current Ratio | 9.30 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 24.51 |
| Assets | 24.51 |
| Liabilities | 17.24 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Armistice Capital, Llc | 8.17 | ||
| 13G/A | Great Point Partners Llc | 9.99 | 0.05 | |
| 13G/A | Sclar Jeremy M. | 19.10 | 77.92 | |
| 13G/A | Gordon Michael S | 14.00 | 77.07 | |
| 13G | Shaf QIC LLC | 9.99 | ||
| 13G/A | Sphera Funds Management Ltd. | 9.99 | 2.16 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 34,620 | 73,009 | 47.42 | |
| 8,149 | 62,649 | 13.01 | |
| 6,498 | 30,223 | 21.50 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PIRS – Pieris Pharmaceuticals, Inc. | PLUR – Pluri Inc. |
| PMCB – PharmaCyte Biotech, Inc. | PRFX – PainReform Ltd. |
| PROK – ProKidney Corp. |
Financial data and stock pages provided by
Fintel.io